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Primary angiosarcoma of the breast is extremely rare. Radiologic findings are often non specific and may appear
completely normal in one-third of cases with primary angiosarcoma. The prognosis is usually poor because of the
high rates of local recurrence and early development of metastasis. Surgical removal followed by adjuvant
chemotherapy seems improve the prognosis.
We report a case of a 33- year-old woman with a highly vascular mass in her right breast which is suggestive of
malignancy at radiology. Initial core needle biopsy showed a benign hemangioma. The patient underwent a
mastectomy. The tumor histology showed papillary formations and vascular structures lined by atypical cells with
hyperchromatic nucleus and eosinophilic cytoplasm with solid areas. The tumor cells expressed CD34 and CD31
but were negative for cytokeratin. The diagnosis of angiosarcoma grade III was made. The patient is now receiving
chemotherapy. She is still alive.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1530481200889780Introduction
Angiosarcoma of the breast is an exceedingly rare dis-
ease that may occur as a primary neoplasm or as a com-
plication of radiation therapy after breast conservation.
Only about 20% of angiosarcomas are primary sarcomas.
The incidence of primary breast angiosarcoma is about
17 new cases per million women [1].
We report this new case in the aim of avoiding the com-
mon trap of a benign differential diagnosis, and achieving
a better definition of the treatment of this cancer.
Case report
We present a case of a 33-year-old woman, with a pain-
ful slowly growing mass in her right breast over a period
of one year. She had no personal or family history of
breast or ovarian cancer. Except the suspect mass, she
was in good health.
The physical exam showed an important asymmetry
at the expense of the right breast lower area and it was
a blackish skin lesion measuring 2 cm in the lower-
medial quadrant. The mass was firm and appears to be
fixed to the skin. It measures 13 × 12 cm. No axillary* Correspondence: bennaniamal@gmail.com
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reproduction in any medium, provided the orlymphadenopathy was palpated. An ultrasound showed
a diffuse and ill delimited hyperechogenic infiltration in
the inferior portion of the right breast which is
hypervascular on doppler sonography. Mammography
showed a non specific and diffuse density area of about
12 cm. There was no microcalcification or distortion.
The conclusion of radiologist was malign finding (BI-
RADS4-5). A core needle biopsy (CNB) was performed
and showed non atypical vascular lesion; this was
interpreted as a benign capillary hemangioma. This dis-
crepancy between radiological finding and histological
results led to the necessity of a macro biopsy.
However, as the mass was so large and highly vascular
at Doppler sonography, macrobiopsy was difficult to per-
form. As consequence, radical mastectomy became more
appropriate.
At gross examination, the mastectomy measured 16 ×
12 cm. The tumor entirely replaces the lower quadrants.
It was blackish, hemorrhagic and measures 9,2 cm in the
greatest dimension (Figure 1). There were mastopathy
lesions with cystic in the upper quadrant.
Histologically, the tumor was made by papillary forma-
tions and vascular structures lined by atypical cells with
hyperchromatic nucleus and eosinophilic cytoplasm. Mi-
toses are estimated to 13mitoses/10 high-power magnifi-
cation (Figures 2 and 3). There were solid areas made ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A blackish hemorrhagic ill defined mass of
lower quadrants.
Figure 3 Vascular structures was lined by atypical cells with
hyperchromatic nucleus and cytoplasm (hematoxylin-eosin-
safran x 40).
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Areas of hemorrhage, known as “blood lakes” and necrosis
are also seen. The tumor invades the skin and causes
its ulceration. Tumor cells are stained with CD31 and
CD34 (Figures 5 and 6). Cytokeratin AE1/AE3 was negative
in solid areas (Figure 7). The diagnosis of grade III
angiosarcoma of the breast was made. The surgical margins
were free of tumor.
Total body CT scan didn’t show any metastasis. Adju-
vant chemotherapy was prescribed to our patient. She is
still alive.
Discussion
Mammary sarcomas are a heterogeneous group of ma-
lignant neoplasms that arise from the mammary stroma
[2]. Angiosarcomas, one of the most common forms of
mammary sarcoma, are developed from the endothelial
lining of the blood vessels [3].Figure 2 The tumor was made bay papillary formations and
vascular structures (hematoxylin-eosin-safran x 5).Breast angiosarcoma can be observed as a primary
neoplasm or, more commonly, is described in upper
limb lymphedema as a result of mastectomy and radio-
therapy for breast carcinoma [4]. Both primary and sec-
ondary breast angiosarcomas carry a prognosis worse
than mammary carcinoma [5]. Synchronous bilateral
angiosarcoma has been reported [5]. In the present
paper, in accordance to the case reported, only primary
angiosarcomas will be discussed.
Primary angiosarcoma of the breast is exceedingly rare,
and represents around 0.04% of malignant breast neo-
plasms. Its incidence among breast sarcomas varies from
2.7% to 9.1% [6]. Breast angiosarcoma is more frequent in
young women (20 to 50 years) like in our case with no
previous cancer history or other known risk factors [7,8].
Between 6 and 12% of primary breast angiosarcomas are
diagnosed during pregnancy or shortly after, suggesting
hormones involvement. However, cases reported to displayFigure 4 There were solid areas made of spindle cell
(hematoxylin-eosin-safran x 10).
Figure 5 Immunohistochemical stains showed diffuse positivity
for CD34 in the neoplastic cells.
Figure 7 Immunohistochemical stains showed negativity for CK
in solid areas.
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impossible to establish a link between angiosarcomas and
hormonal dependency [9,10]. In the case reported here, es-
trogen and progesterone receptors were both negatives.
Therefore, the role of estrogen dependency in angiosarcoma
has yet to be proven and could be subject to future research.
The right breast is more commonly involved than the
left breast [11].
In most published cases, breast angiosarcoma is
presented as a palpable mass, without pain and with a fast
growing rate [11,12].
Radiographically, breast angiosarcomas exhibit no path-
ognomonic features. They often appear as ill-defined
masses on mammograms. Calcifications can be seen but
differ from those seen with breast carcinomas [11]. In a re-
view of radiologic findings with angiosarcomas, LiebermaneFigure 6 Immunohistochemical stains showed diffuse positivity
for CD31.and et al established that the echotexture of these lesions
is highly variable. They conclude that Patients with higher-
grade lesions at pathologic evaluation were significantly
(P less than .05) more likely to have abnormal mammo-
grams, like in our case [13].
In most cases, tumor size at diagnosis is larger than 4
cm [9]. Angiosarcomas larger than 5 cm are associated
to a shorter disease-free survival than angiosarcomas
smaller than 5 cm. Indeed, tumors smaller than 5 cm
are usually associated to a better prognosis, even in the
presence of worsening factors.
Diagnosis prior to surgery, either by FNA (Fine needle
aspiration) or NCB, is always difficult [9]. Chen and
et al. reported a percutaneous biopsy false-negative rate
of 37% [6]. The final diagnosis in doubtful cases was
made by excisionnal biopsy or was based on the patient's
clinical course, which is characterized by episodes of
tumor recurrence [6,14].
In our case, Biopsy showed a benign hemangioma but at
radiology the tumor was ill defined and seemed more
aggressive than a simple hemangioma. So Large-core
macrobiopsy was mandatory. But as the tumor was highly
vascular at doppler sonography, even macrobiopsy was
very difficult to perform, consequently the mastectomy
was done.
After mastectomy, further review of biopsy showed a
few and focal vascular structures lined by atypical cells
without papillary or spindle areas. Those features were
not sufficient to confirm the malignancy.
Pathologically, these tumors are subdivided into three
groups according to the classification proposed by
Donnel and et al [15]. Grade I (well differentiated) con-
tains open anastomosing vascular channels that prolifer-
ate within dermis, subcutaneous tissue or breast tissue.
A single layer of endothelial cells lines these channels,
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little destruction of the preexisting lobules and ducts.
The endothelial cells are usually flat; the nuclei may be
hyperchromatic and contains small nucleoli. Solid and spin-
dle cell foci, blood lakes, and necrosis are not present.
Intermediate-grade angiosarcoma differs from low-grade by
containing additional cellular foci of papillary formations
and/or solid and spindle cell proliferation. The greater part
of the tumor, however, is still composed of low-grade hist-
ology. Slightly increased mitotic activity is observed. In
Rosen's study, intermediate-grade angiosarcomas behave
more like low-grade sarcomas [16]. In grade III endothelial
tufting and papillary formations are prominent. Conspicu-
ous solid and spindle cell areas, mostly devoid of vascular
formations, are present as well. Mitoses may be brisk, espe-
cially in more cellular areas. Areas of hemorrhage, known
as “blood lakes,” and necrosis are also seen.
High grade angiosarcoma may contain low or intermedi-
ate grade elements, especially at the periphery of the
tumor. These elements have deceptively benign appearing
and are well differentiated [7]. This explains the fact that
the majority of NCB biopsies are negative.
The endothelial cells show reactivity for several markers,
including CD31, CD34 and von Willebrand factor (factor
VIII). Among them, CD31 is considered the most sensitive
and most specific endothelial cell marker.
Some papers have documented that epithelioid angio-
sarcoma can express cytokeratin and P63 [17].
Differential diagnosis of this rare tumor include: benign
hemangioma, phyllodes sarcoma, stromal sarcoma, meta-
plastic carcinoma, fibrosarcoma, liposarcoma, squamous
cell carcinoma with sarcomatoid features, myoepithelioma,
fibromatosis, reactive spindle cell proliferative lesion [9],
and high-grade mammary carcinoma especially in small bi-
opsy specimens containing only solid areas. Immunohisto-
chemical stains for epithelial markers (pancytokeratin),
endothelial markers (CD34 and CD31), and other sarcoma
markers should help in making the correct diagnosis.
Surgery is the principal mode of treatment for primary
angiosarcoma of the breast and generally consists of a total
mastectomy. Hematogenous dissemination is the rule, mak-
ing axillary lymph node dissection unnecessary. Chemo-
therapy is observed to be beneficial in high-grade lesions
and in the metastatic setting. Preoperative radiotherapy is
not indicated in the treatment of angiosarcoma [11].
The degree of differentiation has a significant prognos-
tic value, with regard to both local failure and metasta-
ses. Well-differentiated tumors (grade I) have a better
prognosis and a higher survival with lower metastatic
rate. The prognosis for cases of moderate differentiation
is not clear due to the limited number of cases. Other
characteristics of the tumor which are of lower prognos-
tic value include: cellular appearance, infiltration of the
border, number of mitoses and stromal atypia.Conclusion
Young women with solid-appearing breast tumors that are
highly vascular at the time of biopsy should be considered
malignant until proven otherwise. Donnel's method for
grading breast angiosarcoma is easy to implement and
correlates well with clinical outcome.
Consent
Written informed consent was obtained from patient's
parents for publication of this case report and any ac-
companying images.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AB, LC, ML, IB and AA performed the histological examination of the breast
and were major contributors to writing the manuscript. MW, FF and MAM
are the surgeons who operated on the patient and interpreted the patient
data. All authors read and approved the final manuscript.
Acknowledgments
The authors thank Hicham ATMANE who participated in the English
translation of the manuscript.
Author details
1Department of Pathology, HASSAN II University Hospital, Fez 30000,
Morocco. 2Department of Gynecology and Obstetrics, HASSAN II University
Hospital, Fez 30000, Morocco.
Received: 9 January 2013 Accepted: 16 April 2013
Published: 22 April 2013
References
1. Desbiens C, Hogue JC, Levesque Y: Primary Breast Angiosarcoma: Avoiding a
Common Trap, Case Reports in Oncological Medicine. 2011:5. Article ID
517047.
2. Yang G-Z, Li J, Jin H, Ding H-Y: Is mammary not otherwise specified-type
sarcoma with CD10 expression a distinct entity? A rare case report with
immunohistochemical and ultrastructural study. Diagn Pathol 2013, 8:14.
3. Bohn OL, de León E, Lezama O, Rios-Luna NP, Sánchez-Sosa S, Llombart-
Bosch A: Pulmonary artery sarcoma with angiosarcoma phenotype
mimicking pleomorphic malignant fibrous histiocytoma: a case report.
Diagn Pathol 2012, 7:154.
4. Armah HB, Rao UNM, Parwani AV: Primary angiosarcoma of the testis:
report of a rare entity and review of the literature. Diagn Pathol 2007,
2:23.
5. Babarović E, Zamolo G, Mustać E, Strčić M: High grade angiosarcoma
arising in fibroadenoma. Diagn Pathol 2011, 6:125.
6. Chen KTK, Kirkegaard DD, Bocian JJ: Angiosarcoma of the breast. Cancer
1980, 46:368–371.
7. Wang XY, Jakowski J, Tawfik OW, Thomas PA, Fan F: Angiosarcoma of the
breast: a clinicopathologic analysis of cases from the last 10 years. Ann
Diagn Pathol 2009, 13(3):147–150.
8. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC:
Primary and secondary angiosarcoma of the breast: the Mayo Clinic
experience. J Surg Oncol 2010, 101(5):401–407.
9. Ohta M, Tokuda Y, Kuge S, et al: A case of angiosarcoma of the breast.
Jpn J Clin Oncol 1997, 27(2):91–94.
10. Sher T, Hennessy BT, Valero V, et al: Primary angiosarcomas of the breast.
Cancer 2007, 110(1):173–178.
11. Johnson CM, Garguilo GA: Angiosarcoma of the breast: a case report and
literature review. Curr Surg 2002, 59(5):490–494.
12. Georgiannos SN, Sheaff M: Angiosarcoma of the breast: a 30 year
perspective with an optimistic outlook. Br J Plast Surg 2003, 56(2):129–134.
13. Liberman L, Dershaw DD, Kaufman RJ, Rosen PP: Angiosarcoma of the
breast. Radiology 1992, 183:649–654.
Bennani et al. Diagnostic Pathology 2013, 8:66 Page 5 of 5
http://www.diagnosticpathology.org/content/8/1/6614. Rainwater LM, Martin K, Gaffey TA, Van Heerden JA: Angiosarcoma of the
breast. Arch Surg 1986, 121:669–672.
15. Donnell RM, Rosen PP, Liberman PH, et al: Angiosarcoma and other
vascular tumors of the breast. Am J Surj Pathol 1981, 5:629–642.
16. Rosen PP, Kimmel M, Ernsberger D: Mammary angiosarcoma: the
prognostic significance of tumor differentiation. Cancer 1988,
62:145–2151.
17. Lin X-Y, Liu Y, Zhang Y, Yu J-H, Wang E-H: The co-expression of
cytokeratin and p63 in epithelioid angiosarcoma of the parotid gland: a
diagnostic pitfall. Diagn Pathol 2012, 7:118.
doi:10.1186/1746-1596-8-66
Cite this article as: Bennani et al.: Primary angiosarcoma of the breast: a
case report. Diagnostic Pathology 2013 8:66.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
